RE:RE:RE:RE:RE:Interim Data...Pretty stable and awesome data. 270 days is looking better. especially when combining CR plus IR, and overall with optimized treatment we can see we would get about 5-10% increase in CR in the end. So I'm expecting overall after 100 patients about 45% CR at 450 days. It could end up higher, but I will be happy with anything over 35%. We are clearly over 30% benchmark. BTD is taking a bit longer, but at least the FDA is getting familiar with our tech and data with all these back and forths.. This tells me that AA could follow shortly after. All IMHO